Jazz Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Jazz Pharmaceuticals using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-05 | $8.13 | $5.43 | 49.7 % |
| Q2 | 2025-08-05 | $-8.25 | $-6.34 | -30.1 % |
| Q1 | 2025-05-06 | $1.68 | $4.66 | -63.9 % |
| Q4 | 2025-02-25 | $6.60 | $5.81 | 13.6 % |
Jazz Pharmaceuticals (JAZZ) is scheduled to report earnings on February 24, 2026. The last reported earnings were for reported on November 5, 2025 for Q3.
The Actual EPS was $8.13, which beat the estimate of $5.43.
The Actual Revenue was $1.13B, which beat the estimate of $1.11B.
Browse earnings estimates, EPS, and revenue on all stocks.
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-05 | $1.13B | $1.11B | 1.89 % |
| Q2 | 2025-08-05 | $1.05B | $1.05B | -0.22 % |
| Q1 | 2025-05-06 | $897.84M | $983.75M | -8.73 % |
| Q4 | 2025-02-25 | $1.09B | $1.06B | 2.64 % |